The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior

被引:137
作者
Heinrichs, SC
Richard, D
机构
[1] Boston Coll, Dept Psychol, Chestnut Hill, MA 02467 USA
[2] Univ Laval, Fac Med, Ctr Rech Metab Energet, Quebec City, PQ G1K 7P4, Canada
关键词
D O I
10.1054/npep.1999.0047
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Participation of the hypathalamo-pituitary-adrenocortical axis, and its primary brain trigger, corticotropin-releasing factor (CRF) in the control of ingestive behavior can be inferred from data suggesting that CRF and its homologue urocortin act in brain to limit appetite following administration in rodents. Moreover, levels of endogenous CRF, CRF, and CRF, receptors and CRF-binding protein, which sequesters CRF and urocortin, are altered by changes in nutritional status brought about by food restriction/repletion. Mediation of the anorexic effects of CRF and urocortin appear not to privilege CRF, receptors, unlike the anxiogenic effects of CRF which are primarily a consequence of CRF, receptor activation. Such fear-like consequences of CRF system activation constitute a non-specific mechanism whereby the emergence of behaviors incompatible with food intake may appear to suppress appetite without affecting hunger per se. However, enhanced appetite following administration of CRF receptor antagonists and the involvement of CRF systems in sexual appetite and drug-seeking behavior all suggest a role for CRF in ingestive behavior. In particular, available evidence suggests that physiologically relevant suppression of appetite may accompany CRF system activation occurring as a consequence of stressor exposure induced by nutrient imbalance, for example, or under conditions of excessive intake or consumption of unfamiliar foodstuffs. (C) 1999 Harcourt Publishers Ltd.
引用
收藏
页码:350 / 359
页数:10
相关论文
共 103 条
[1]   Role of leptin in the neuroendocrine response to fasting [J].
Ahima, RS ;
Prabakaran, D ;
Mantzoros, C ;
Qu, DQ ;
Lowell, B ;
MaratosFlier, E ;
Flier, JS .
NATURE, 1996, 382 (6588) :250-252
[2]  
[Anonymous], 1994, AM PSYCHIATR ASSOC
[3]   EFFECTS OF INTRAVENTRICULAR INFUSION OF CORTICOTROPIN-RELEASING FACTOR ON VMH-LESIONED OBESE RATS [J].
ARASE, K ;
SHARGILL, NS ;
BRAY, GA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (03) :R751-R756
[4]   Pharmacological characterisation of the recombinant human CRF binding protein using a simple assay [J].
Ardati, A ;
Gottowik, J ;
Henriot, S ;
Clerc, RG ;
Kilpatrick, GJ .
JOURNAL OF NEUROSCIENCE METHODS, 1998, 80 (01) :99-105
[5]   RAPID AND LOCALIZED ALTERATIONS OF NEUROPEPTIDE-Y IN DISCRETE HYPOTHALAMIC NUCLEI WITH FEEDING STATUS [J].
BECK, B ;
JHANWARUNIYAL, M ;
BURLET, A ;
CHAPLEURCHATEAU, M ;
LEIBOWITZ, SF ;
BURLET, C .
BRAIN RESEARCH, 1990, 528 (02) :245-249
[6]   DISPLACEMENT OF CORTICOTROPIN-RELEASING FACTOR FROM ITS BINDING-PROTEIN AS A POSSIBLE TREATMENT FOR ALZHEIMERS-DISEASE [J].
BEHAN, DP ;
HEINRICHS, SC ;
TRONCOSO, JC ;
LIU, XJ ;
KAWAS, CH ;
LING, N ;
DESOUZA, EB .
NATURE, 1995, 378 (6554) :284-287
[7]  
Behan DP, 1996, BRAIN RES, V725, P263, DOI 10.1016/S0006-8993(96)00347-2
[8]  
Behan DP, 1996, MOL PSYCHIATR, V1, P265
[9]  
BENOIT SC, UNPUB COMPARISON CEN
[10]   Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland - Leptin inhibits cortisol release directly [J].
Bornstein, SR ;
Uhlmann, K ;
Haidan, A ;
EhrhartBornstein, M ;
Scherbaum, WA .
DIABETES, 1997, 46 (07) :1235-1238